NKTR - NEKTAR THERAPEUTICS

QQQ $ 475.24 $ 0.61 (0.13 %)

DIA $ 406.80 $ 0.86 (0.21 %)

SPY $ 554.24 $ 1.24 (0.22 %)

TLT $ 97.41 $ 0.34 (0.35 %)

GLD $ 231.90 $ 5.08 (2.24 %)

Previous Close

$ 1.25

Open

Bid

$ 1.24 x 700

Ask

$ 1.25 x 600

Day's Range

-- - --

52 Week Range

$ 0.41 - $ 1.93

Volume

654,992

Average Volume

Market Cap

261.04M

Beta (5Y Monthly)

$ 0.94

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-05-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	02-28-2023	12-31-2022	10-K
8	11-04-2022	09-30-2022	10-Q
9	08-05-2022	06-30-2022	10-Q
10	05-06-2022	03-31-2022	10-Q
11	02-28-2022	12-31-2021	10-K
12	11-05-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-07-2021	03-31-2021	10-Q
15	02-26-2021	12-31-2020	10-K
16	11-06-2020	09-30-2020	10-Q
17	08-07-2020	06-30-2020	10-Q
18	05-08-2020	03-31-2020	10-Q
19	02-28-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-09-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	03-01-2019	12-31-2018	10-K
24	11-08-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	03-01-2018	12-31-2017	10-K
28	11-08-2017	09-30-2017	10-Q
29	08-09-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	03-01-2017	12-31-2016	10-K
32	11-04-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	05-04-2016	03-31-2016	10-Q
35	02-29-2016	12-31-2015	10-K
36	11-06-2015	09-30-2015	10-Q
37	08-06-2015	06-30-2015	10-Q
38	05-01-2015	03-31-2015	10-Q
39	02-26-2015	12-31-2014	10-K
40	11-07-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Nektar Therapeutics Q2 2024 GAAP EPS $(0.2...
08/08/2024 21:40:56

Nektar Therapeutics (NASDAQ:NKTR) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of...

Nektar Therapeutics Presents First Preclin...
06/12/2024 13:40:12

– NKTR-0165 Demonstrates Selective Enhancement of Treg Cell Function Through Novel Agonistic Mechanism –– IND-Enabling Studies ...

Nektar Therapeutics Q1 2024 GAAP EPS $(0.1...
05/09/2024 22:52:55

Nektar Therapeutics (NASDAQ:NKTR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $...

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
05/07/2024 20:31:08

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 12:06:42

Nektar Therapeutics Receives Letter That I...
04/17/2024 21:16:38

To regain compliance with the Minimum Bid Price Requirement, the Company’s common stock was required to maintain a closing bid ...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
04/11/2024 16:31:52

Jefferies Maintains Hold on Nektar Therape...
03/06/2024 14:44:37

Jefferies analyst Roger Song maintains Nektar Therapeutics (NASDAQ:NKTR) with a Hold and raises the price target from $0.5 t...

Nektar Therapeutics Announces Initiation O...
03/05/2024 14:09:23

Nektar Therapeutics (NASDAQ:NKTR), a biotechnology company developing medicines for the treatment of auto-immune disorders, tod...

Nektar Therapeutics Q4 2023 GAAP EPS $(0.2...
03/04/2024 21:24:56

Nektar Therapeutics (NASDAQ:NKTR) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $...

why-bitdeer-technologies-shares-are-trading-higher-by-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Bitdeer Technologies Shares Are Tradin...
03/04/2024 18:29:18

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported prelimina...

Nektar Therapeutics Announces $30M Private...
03/04/2024 13:37:53

Nektar Therapeutics (NASDAQ:NKTR), a biotechnology company developing medicines for the treatment of auto-immune disorders, tod...

Earnings Scheduled For March 4, 2024
03/04/2024 09:53:45

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.

Nektar Therapeutics Earnings Preview
03/01/2024 16:00:41

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
01/12/2024 21:31:10

Nektar And Collaborators Present Preclinic...
12/11/2023 23:02:17

JP Morgan Reinstates Underweight on Nektar...
11/20/2023 13:29:37

JP Morgan analyst Jessica Fye reinstates Nektar Therapeutics (NASDAQ:NKTR) with a Underweight.

TD Cowen Upgrades Nektar Therapeutics to O...
11/09/2023 14:18:43

TD Cowen analyst Chris Shibutani upgrades Nektar Therapeutics (NASDAQ:NKTR) from Market Perform to Outperform.

Recap: Nektar Therapeutics Q3 Earnings
11/07/2023 21:40:46

Earnings Scheduled For November 7, 2023
11/07/2023 11:34:30

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.